Ashkan Javaherian, PhD
Download a Printable PDF
More about Dr. Javaherian
Dr. Javaherian's research goal is to help create and establish cellular models of neurodegenerative diseases in a dish—using neurons derived from induced pluripotent stem (iPS) cells—in order to investigate the underlying mechanisms of disease and discover new therapies. Currently, he is screening compounds for their ability to prevent neuronal death in both animal and human-derived cellular models of Huntington’s disease and Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig’s disease).
Prior to joining Gladstone as a Staff Research Scientist in 2013, Dr. Javaherian was a senior scientist and program leader at iPierian, Inc., a biopharmaceutical company, where he developed iPS cells derived from ALS patients for drug discovery purposes. His work at iPerian, Inc., earned him an ALS Association Award in 2011.
After completing his PhD in genetics at Stony Brook University in New York, Dr. Javaherian was a postdoctoral scholar at the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at the University of California, San Francisco, under the guidance of the Center’s director, Dr. Arnold Kriegstein.